What medical communications has taught me that academia didn’t

One month into my role at Oxford PharmaGenesis has taught me more about scientific and medical publishing than 6 years in the world of academic research. Here, I discuss some of the key issues around academic publishing, and how some researchers in academia could learn from best practices developed to ensure compliance, transparency and integrity in the medical communications industry.

Evidence-based medicine no more?

In a pre-COVID-19 world, this week would have seen evidence-based medicine experts gather in Toronto for EBM Live 2020. However, like many other meetings during the pandemic, it has been postponed. Here, I reflect on last year’s meeting and pharma’s journey in improving the reporting of clinical trials.